Entries by biopoly

Polyganics Initiates First-in-Human Trial of LIQOSEAL®, its Innovative Approach for Dural Closure

Groningen, The Netherlands, 22 October 2018 – Polyganics, a medical technology company developing, manufacturing and commercializing bioresorbable medical devices, today announced that it has initiated enrollment of patients into a first-in-human clinical trial of LIQOSEAL®, its dura sealant patch. The self-adhesive patch has been developed to reduce cerebrospinal fluid (CSF) leakage following brain surgery The […]

Polyganics Strengthens Global Distribution Network with Appointment of Synovis MCA as US-wide Distributor of NEUROCAP®

Groningen, The Netherlands – 10 September 2018 – Polyganics, a privately held medical technology company that develops, manufactures and commercializes bioresorbable medical devices, today announced that it has signed an agreement with Synovis Micro Companies Alliance Inc. (“Synovis MCA”), a subsidiary of Baxter International Inc., to be the exclusive distributor of its nerve capping device, […]

FESSH Congress 2018 – Working for the Future

FESSH Congress 2018 – Working for the Future 13-16 June 2018 Copenhagen, Denmark Visit stand 14 Workshop Session Peripheral Nerve Repair Solutions, Transforming Patient Recovery (S85) Date and Time: 13:00 – 13:50, Friday, 15 June 2018 Location: Arkaden 8, Tivoli Congress Center Speakers: Michael Wheatley, Dominic Power, Nefer Fallico Agenda available, here. Poster Presentation Neuroma […]